Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Renaud Mahieux & Olivier Hermine. (2005) In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-a. Leukemia & Lymphoma 46:3, pages 347-355.
Read now
Read now
Quan Chen, Subrata Ray, Mohamad A. Hussein, Gordan Srkalovic & Alexandru Almasan. (2003) Role of Apo2L/TRAIL and Bcl-2-family Proteins in Apoptosis of Multiple Myeloma. Leukemia & Lymphoma 44:7, pages 1209-1214.
Read now
Read now
Ming-Jer Huang, Ruey-Kuen Hsieh, Che-pin Lin, Ian Y Chang & Hsing-Jin Liu. (2002) The Cytotoxicity of Arsenic Trioxide to Normal Hematopoietic Progenitors and Leukemic Cells is Dependent on Their Cell-cycle Status. Leukemia & Lymphoma 43:11, pages 2191-2199.
Read now
Read now
Articles from other publishers (19)
Archana Chaudhary, Ghulam Mohammad Ashraf, Md. Margoob Ahmad, Manish Kumar & Rizwanul Haque. 2023. Arsenic Toxicity Remediation: Biotechnological Approaches. Arsenic Toxicity Remediation: Biotechnological Approaches
61
84
.
Lynn Chin, Cyrus R. Kumana, Yok-Lam Kwong & Harinder Gill. (2022) The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases. Pharmaceutics 14:9, pages 1945.
Crossref
Crossref
Archana Chaudhary & Rizwanul Haque. 2021. Arsenic Toxicity: Challenges and Solutions. Arsenic Toxicity: Challenges and Solutions
301
324
.
Anatoly V. Skalny, Thania Rios Rossi Lima, Tao Ke, Ji-Chang Zhou, Julia Bornhorst, Svetlana I. Alekseenko, Jan Aaseth, Ourania Anesti, Dimosthenis A. Sarigiannis, Aristides Tsatsakis, Michael Aschner & Alexey A. Tinkov. (2020) Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases. Food and Chemical Toxicology 146, pages 111809.
Crossref
Crossref
SUIJING WU, LING XU, XIN HUANG, SUXIA GENG, YAN XU, SHAOHUA CHEN, LIJIAN YANG, XIULI WU, JANYU WENG, XIN DU & YANGQIU LI. (2016) Arsenic induced complete remission in a refractory T-ALL patient with a distinct T-cell clonal evolution without molecular complete remission: A case report. Oncology Letters 11:6, pages 4123-4130.
Crossref
Crossref
Marc Beyer, Staffan Vandersee, Ioana Cosagarea, Rachid Touba, Markus Möbs & Chalid Assaf. (2016) The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell Lines. Skin Pharmacology and Physiology 29:2, pages 63-70.
Crossref
Crossref
Hongtao Wang, Peng Gao & Jie Zheng. (2014) Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells. Biochemical and Biophysical Research Communications 451:4, pages 556-561.
Crossref
Crossref
Ines Mancini & Andrea Defant. 2013. Biomedical Inorganic Polymers. Biomedical Inorganic Polymers
175
195
.
Chih‐Hung Lee, Wei‐Ting Liao & Hsin‐Su Yu. (2011) Aberrant immune responses in arsenical skin cancers. The Kaohsiung Journal of Medical Sciences 27:9, pages 396-401.
Crossref
Crossref
Wensheng Yan, Yanhong Zhang, Jin Zhang, Shou Liu, Seong Jun Cho & Xinbin Chen. (2011) Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression. Journal of Biological Chemistry 286:20, pages 17478-17486.
Crossref
Crossref
Chih-Hung Lee, Wei-Ting Liao & Hsin-Su Yu. (2010) Mechanisms and Immune Dysregulation in Arsenic Skin Carcinogenesis. Journal of Cancer Therapy 01:02, pages 76-86.
Crossref
Crossref
Magdalena Izdebska, Dariusz Grzanka, Lidia Gackowska, Agnieszka Żuryń & Alina Grzanka. (2009) The influence of Trisenox on actin organization in HL-60 cells. Open Life Sciences 4:3, pages 351-361.
Crossref
Crossref
John M. Taylor & Christophe Nicot. (2008) HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis 13:6, pages 733-747.
Crossref
Crossref
Xiao-Fang CheChun-Lei ZhengSatsuki OwatariMasato MutohTakenari GotandaHei-Cheul JeungTatsuhiko FurukawaRyuji IkedaMasatatsu YamamotoMisako HaraguchiNaomichi ArimaShin-ichi Akiyama. (2006) Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines. Blood 107:12, pages 4880-4887.
Crossref
Crossref
Ryungsa Kim, Manabu Emi & Kazuaki Tanabe. (2005) Role of mitochondria as the gardens of cell death. Cancer Chemotherapy and Pharmacology 57:5, pages 545-553.
Crossref
Crossref
Alessio Nencioni, Lucia Wille, Giovanna Dal Bello, Davide Boy, Gabriella Cirmena, Sebastian Wesselborg, Claus Belka, Peter Brossart, Franco Patrone & Alberto Ballestrero. (2005) Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells. Clinical Cancer Research 11:11, pages 4259-4265.
Crossref
Crossref
Timothy M Kuzel, Richard Junghans & Francine M Foss. (2003) Novel agents for cutaneous T-cell lymphoma. Hematology/Oncology Clinics of North America 17:6, pages 1459-1466.
Crossref
Crossref
Ann M. Bode & Zigang Dong. (2002) The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Critical Reviews in Oncology/Hematology 42:1, pages 5-24.
Crossref
Crossref
Renaud MahieuxCynthia Pise-MasisonAntoine GessainJohn. N. BradyRené OlivierEmmanuelle PerretTom MisteliChristophe Nicot. (2001) Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1– and type 2–infected cells by a caspase-3–dependent mechanism involving Bcl-2 cleavage. Blood 98:13, pages 3762-3769.
Crossref
Crossref